ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
Dow Jones
43,297.03
0.91%
US Dollar vs MXN
20.18368
0.00%
Brent Oil
73.285
0.80%
Bitcoin
98,671.28
4.20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Brasil
  5. BOV

  6. Astrazeneca plc (A1ZN34) Cotización

Astrazeneca plc

Astrazeneca plc (A1ZN34)

BOV
68.70
2.58
(3.90%)
Cerrado 24 Diciembre 2:55PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
68.92
Postura de Compra
65.93
Postura de Venta
70.11
Volume Operado de la Acción
811
67.34 Rango del Día 68.70
50.80 Rango de 52 semanas 82.80
Capitalización de Mercado [m]
106.837B
Precio Anterior
66.12
Precio de Apertura
67.48
Hora
100
@
68.92
Última hora de negociación
Volumen financiero
R$ 55,562
Precio Promedio Ponderado
68.511
Volumen promedio (3 m)
1,937
Acciones en circulación
1,550,163,000
Rendimiento del Dividendo
1.84%
Ratio Precio/Utilidad
27.17
Beneficio por acción (BPA)
3.84
turnover
45.81B
Beneficio neto
5.96B

Acerca de Astrazeneca plc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Cambridge, Gbr
Fundado
-
Astrazeneca plc is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker A1ZN34. The last closing price for Astrazeneca was R$66.12. Over the last year, Astrazeneca shares have traded in a share price range of R$ 50.80 to R$ 82.80.

Astrazeneca currently has 1,550,163,000 shares in issue. The market capitalisation of Astrazeneca is R$102.50 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 27.17.

A1ZN34 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
11.422.103703703767.568.9364.7568867.51708261DR
45.198.143731366763.737063.3246468.00620422DR
12-1.57-2.227266278970.4974.5659.52193768.28454758DR
26-2.77-3.863858278771.6982.859.52255174.52417878DR
5215.2728.462255358853.6582.850.8252067.35871127DR
15614.2326.019381971154.6982.846.87264858.01038561DR
26018.937.784886045650.0282.841.72603551.14782038DR

A1ZN34 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Astrazeneca?
El precio actual de las acciones de Astrazeneca es R$ 68.92
¿Cuántas acciones de Astrazeneca están en circulación?
Astrazeneca tiene 1,550,163,000 acciones en circulación
¿Cuál es la capitalización de mercado de Astrazeneca?
La capitalización de mercado de Astrazeneca es BRL 102.5B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Astrazeneca?
Astrazeneca ha negociado en un rango de R$ 50.80 a R$ 82.80 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Astrazeneca?
El ratio precio/beneficio de Astrazeneca es 27.17
¿Cuál es el ratio de efectivo a ventas de Astrazeneca?
El ratio de efectivo a ventas de Astrazeneca es 3.53
¿Cuál es la moneda de reporte de Astrazeneca?
Astrazeneca presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Astrazeneca?
El último ingresos anual de Astrazeneca es USD 45.81B
¿Cuál es el último beneficio anual de Astrazeneca?
El último beneficio anual de Astrazeneca es USD 5.96B
¿Cuál es la dirección registrada de Astrazeneca?
La dirección registrada de Astrazeneca es 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
¿En qué sector industrial opera Astrazeneca?
Astrazeneca opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
COCE11Cia Energetica Ceara Coelce
R$ 1.15
(342.31%)
130k
ESTR4Manufatura Brinquedos Estrela Sa
R$ 4.98
(39.89%)
200
AZEV11Azevedo Travassos Sa
R$ 0.24
(20.00%)
30.4k
OSXB3OSX Brasil SA
R$ 3.80
(11.44%)
2.6k
AMBP3Ambipar Participacoes e Empreendimentos SA
R$ 140.00
(10.24%)
214.9k
TKNO3Tekno Sa Ind Com
R$ 40.70
(-45.73%)
9.8k
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
TKNO4Tekno Sa Ind Com
R$ 55.20
(-20.00%)
7.7k
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
CBEE3Ampla Energia Servicos Sa
R$ 10.01
(-16.58%)
600
HAPV3Hapvida Participacoes Investimento SA
R$ 2.25
(-5.46%)
70.23M
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.86
(0.027137%)
43.79M
ABEV3Ambev SA
R$ 12.22
(-0.08%)
40.18M

Discusión

Ver feed completo
northam43 northam43 3 minutos hace
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/24/kpoid6.1_Short_Term.png
martyDg martyDg 3 minutos hace
How can they sell the company if they can't even secure UK approval, especially when that's under LP's domain? The MHRA is just as slow as NWBO's management. If they can't get approval from the UK, imagine how long it would take to get approval from the US FDA—they'd probably leave the paperwork sit
NWBO
nilremerlin nilremerlin 4 minutos hace
50 dma now up to .60 above the 200 dma, further confirming the integrity of the Golden Cross.
VWAP 3.13 US, uP today.
Close $3.14 US, uP today.
Volume was less than the average today.
$3 US VWAP close was achieved on
10/29/24.
Above $3 US VWAP close achieved
HITI
againstallodds againstallodds 4 minutos hace
PDIV A TOXIC SHARE SELLING SCAM
PDIV
Edward Edward 5 minutos hace
Funny, i am blocked and still my posts are read. LOL!


Criminal charges are coming!


The SEC has extremely broad investigative and enforcement powers, it cannot file criminal charges. It can, and often does, work with the Department of Justice and the Unit
VXIT
northam43 northam43 6 minutos hace
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/24/enjxe6_All_Cycles_Chart.png
gedi8 gedi8 6 minutos hace
Back at you my friend.
NXPL
nunaka nunaka 6 minutos hace
You always sound like such a petty, silly kid.
RDGL
mailman69 mailman69 8 minutos hace
Left a word out
I agree with you
It tends to post misleading information in my opinion
VXIT
searay2701 searay2701 9 minutos hace
What a present for Christmas, thank you Lord and everyone who said basically hang in here, they were right on. Hopefully we will see a continual revenue increase per quarter to quarter in 2025 and we will know for sure, going ahead, that things have changed with IVDN LAND for good.
Merry C
IVDN
Shareing is winning Shareing is winning 9 minutos hace
Oops! Something gone wrong here!
Our engineers have noticed the problem and we are working on it now!

In the meantime, try logging out, clearing your cookies and cache for advfn.com (most browsers will let you clear a single domain instead of clearing all your cookies), then l
georgie18 georgie18 9 minutos hace
Happy Holidays Y'all...🥳
jimr1717 jimr1717 9 minutos hace
Quick buy two shares and get this pig painted
NFTM
georgie18 georgie18 9 minutos hace
Happy Holidays Y'all...🥳
igotthemojo igotthemojo 9 minutos hace
"IGTM, it has bipartisan support"

it has a few self serving politicians whose districts will benefit that are for it...that isnt "bipartisan support"...

"creates manufacturing jobs in the US"

so does chewing gum...its not an issue anyone really cares abou
PLUG
NeoSunTzu NeoSunTzu 10 minutos hace
You overreact without having the information you need to make intelligent relevant remarks with just about every discussion on this board. READ THE ARTICLE! This NOT just banks, but other organizations like Chambers of Commerce and other business groups, who are looking NOT to eliminate stress tests
FNMA
jimr1717 jimr1717 10 minutos hace
It really doesn’t matter. No one is short this scam.
IFUS
tat4tat tat4tat 10 minutos hace
There they go again with talking around the main issues with redundant BS. What new avenues. Maybe they mean Conquer sales; or mushroom coffee. Will the CEO start marketing posters of herself for the masses. What about the Q being filed, or is that just a frivolous matter to them. Why are they not a
CEOS
martyDg martyDg 10 minutos hace
NWBO is largely done with getting BLA ready for FDA; they just want to apply any minor modifications learned from MHRA submission

Why don't they issue a pr stating that they are in the process of preparing the BLA submission, as they did with the MAA submission? No news means you're f
NWBO
3Angels120702 3Angels120702 10 minutos hace
Not the first OTC scam I've run into
MWWC
MasterBlastr MasterBlastr 11 minutos hace
Alliance of Diehards, Season 2 Week #18
Alliance of Diehards, Season 2 ends Dec 31, 2024
There are no plans for Season 3, but I will instead create contests that are open to all Draftkings members.

DP World Tour Fantasy League for 2025 has begun - https://
Paulie Pennies Paulie Pennies 11 minutos hace
Merry Christmas folks 😎
ASII
sloppyjones sloppyjones 11 minutos hace
11:59.59 tonight. Lol

Merry Christmas everyone!
TPTW
Pineywoods Pineywoods 12 minutos hace
Now that has a good ring to it!  Go BIEL $$
BIEL

Su Consulta Reciente

BOV
A1ZN34
Astrazeneca
BIT
P1R5E3
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados